-
Stem Cells May be Key to Curing Retinal Disease
Robin Ali, Ph.D., UCL Institute of Ophthalmology in London, has developed a strategy for repairing the retina by transplanting photoreceptor cells generated in the laboratory from embryonic stem cells.Full story -
Organoids Offer Stem Cell Experts a Window into Kidney Disease
Stem cell researchers are now using organoids, lab-grown models of human organs, to better understand kidney disease. In the future, organoids may also provide an important test model for experimental drugs.Full story -
Member Spotlight on Tenneille Ludwig, PhD
What unusual profession helped Dr. Ludwig pay for two years of school? How did she become director of the WiCell Stem Cell Bank and not an IVF clinic as she envisioned? Find out in this month's Member Spotlight.Full story -
2014 ISSCR Election Results Announced
The ISSCR congratulates the winners of the 2014 Elections. New officers and members of the ISSCR Board of Directors will begin their terms in June 2014 following the conclusion of the ISSCR 12th Annual Meeting in Vancover, Canada.Full story -
Details of ISSCR 12th Annual Meeting
The ISSCR 12th Annual Meeting will take place June 18-21, 2014 at the Vancouver Convention Centre in Vancouver, British Columbia, Canada. The meeting will bring together approximately 4,000 stem cell scientists, bioethicists, clinicians and industry professionals from over 50 countries to present and discuss the latest research and technologies within the field.Full story -
Human Disease Modeling Under the Microscope
Induced pluripotent stem cells (iPS cells) have been hailed as a future cell therapy, but they are playing an equally important role in research, revolutionizing the way scientists study human disease. By cultivating human stem cell lines in a dish, scientists are better able to understand diseases, including those with unique genetic markers.Full story -
Late Breaking Abstracts are now being accepted for the ISSCR 12th Annual Meeting
New for 2014, the ISSCR is now accepting Late Breaking Abstracts to be considered for poster presentations at the upcoming ISSCR 12th Annual Meeting, June 18-21 in Vancouver, Canada.Full story -
Two Papers Open a New Window into Pluripotency
The ISSCR is pleased to help spread the news about two papers published online today in Nature that describe the induction of pluripotency in cells from a newborn mouse without the use of extrinsic transcription factors, chemical manipulation or nuclear transfer.Full story -
The ISSCR Announces 2014 Awards Recipients
The ISSCR announces recipients of its 2014 awards, which will be presented at the 12th Annual Meeting in Vancouver, taking place June 18-21, 2014.Full story -
Workshop, "Stem Cell Therapies: Opportunities for Assuring the Quality and Safety of Unregulated Clinical Offerings"
The ISSCR, the Institute of Medicine and the National Academy of Sciences, is hosting a Washington, DC-based workshop and live webcast examining the practice and consequences of unproven stem cell treatments on November 18, 2013 from 8:30 a.m.-5:30 p.m. EDTFull story -
ISSCR Statement of Delivery of Unproven Autologous Cell-based Interventions to Patients
The International Society for Stem Cell Research (ISSCR) urges medical licensing bodies, legal authorities, patient advocacy organizations, physicians, and others to exercise their influence to discourage commercial provision of unproven autologous cell-based interventions outside of clinical trials.Full story -
ISSCR Celebrates Inaugural Issue of its Open Access Journal, Stem Cell Reports
The International Society for Stem Cell Research (ISSCR) is excited to announce the inaugural issue of Stem Cell Reports, the society’s new open-access journal, published today. Stem Cell Reports, published for the ISSCR by Cell Press, presents high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine, with a focus on shorter, single-point articles.Full story -
ISSCR Emphasizes Importance of Regulatory Oversight for Stem Cell Products for Clinical Use
The ISSCR urges Italian lawmakers to heed concerns of scientists around the world about the premature practice of unproven stem cell treatments and to recognize the importance of regulatory oversight and patient protection when developing new stem cell medicines.Full story -
ISSCR Voices Concern as Italian Government Authorizes Unproven Stem Cell Therapy
The International Society for Stem Cell Research (ISSCR) voices concern as the Italian government authorizes an unproven stem cell therapy for use in patients.Full story -
ISSCR President, Board Member, and 11th Annual Meeting Keynote Speaker Among Winners of Breakthrough Prize
ISSCR President, Shinya Yamanaka, Board of Directors member Hans Clevers and the ISSCR 2013 Annual Meeting Keynote Speaker Eric Lander, were three of 11 distinguished recipients of the inaugural Breakthrough Prize in Life Sciences, announced todayFull story -
ISSCR Statement on U.S. Supreme Court decision to deny certiorari in case of Sherley v. Sebelius
The International Society for Stem Cell Research (ISSCR) welcomes the decision of the US Supreme Court to deny certiorari in the case of Sherley v Sebelius, which had challenged federal funding of human embryonic stem cell research.Full story -
ISSCR to Launch Open Access Journal, Stem Cell Reports
The International Society for Stem Cell Research (ISSCR) announces the launch of Stem Cell Reports, its new online, open-access journal. With a focus on shorter, single-point articles, Stem Cell Reports will publish high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine.Full story -
ISSCR Reaffirms Support for All Forms of Stem Cell Research
The ISSCR further congratulates Drs. Shinya Yamanaka and John Gurdon for their scientific achievements recognized by this year's Nobel Prize and reaffirms support for all forms of stem cell research.Full story -
The ISSCR Congratulates Yamanaka and Gurdon on Nobel Prize
The International Society for Stem Cell Research (ISSCR) congratulates its 2011 McEwen Award recipient and current president Shinya Yamanaka, and fellow stem cell pioneer, Sir John Gurdon, on winning the Nobel Prize for Physiology or Medicine, announced today.Full story -
ISSCR Statement on Court Decision Upholding a Dismissal of Challenges to Federal Funding of Human Embryonic Stem Cell Research
The International Society for Stem Cell Research (ISSCR) welcomes the finding of the U.S. Court of Appeals for the District of Columbia upholding an earlier dismissal of Sherley v Sebelius, a court case that had challenged federal funding of human embryonic stem cell research.Full story -
The ISSCR Selects Yokohama, Japan, for its 10th Annual Meeting; First in Asia
The ISSCR will hold its 10th annual meeting June 13-16, 2012, in Yokohama, Japan, at the PACIFICO Yokohama.Full story -
ISSCR Emphasizes Rigorous Oversight for Application of Stem Cell-Based Treatments
The ISSCR is concerned that some stem cell treatments are being prematurely offered to patients without safeguards in place to ensure safety and efficacy.Full story -
ISSCR Honors Stem Cell Research Pioneer with Prestigious McEwen Award for Innovation
The ISSCR is pleased to announce the winner of the 2012 McEwen Award for Innovation, a coveted prize in the field of stem cell research and regenerative medicine. The 2012 recipient is Rudolf Jaenisch, MD, Founding Member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of TechnologyFull story -
ISSCR Statement on Recent Somatic Cell Nuclear Transfer (SCNT) Breakthrough: An Important Step Forward
The International Society for Stem Cell Research (ISSCR) welcomes today’s announcement of an advance in stem cell science and reprogramming through somatic cell nuclear transfer or SCNT.Full story -
ISSCR Statement on U.S. Court Decision to Dismiss Challenges to Federal Funding of Human Embryonic Stem Cell Research
The ISSCR applauds the decision announced today by the U.S. District Court for the District of Columbia in the case of Sherley v. Sebelius, dismissing challenges to the U.S. National Institutes of Health’s (NIH’s) funding of human embryonic stem cell research.Full story -
ISSCR Statement on Advocate General Opinion in Case C-34/10, Brüstle v Greenpeace eV
The ISSCR reiterates its statement of April below in support of hESC research and policies that promote the responsible development of new therapies.Full story -
ISSCR Decries Negative Impact of Stem Cell Injunction on Science and Medicine
Vital progress in stem cell research by hundreds of U.S. laboratories is threatened after last week’s injunction prohibiting federal funding for the study of human embryonic stem cells (hESCs).Full story -
ISSCR Launches Web Site Providing Information on Stem Cell Treatments
The ISSCR announced today that it has launched "A Closer Look at Stem Cell Treatments" (www.closerlookatstemcells.org), a Web site to arm patients, their families and doctors with information they need to make decisions about stem cell treatmentsFull story -
ISSCR Comments on NIH Draft Guidelines for Embryonic Stem Cell Funding
In the interest of improving world health we urge the NIH to open discussions on funding research carried out with human pluripotent stem cell lines derived from sources other than excess reproductive IVF embryos, including SCNT embryos, if they become available and are derived under rigorous ethical standards.Full story -
Stem Cell Society Leaders Receive Nation's Top Science Awards
The ISSCR congratulates two board members who were named recipients of two of the nation’s top science awards, Shinya Yamanaka, MD, PhD (Kyoto University), and Elaine Fuchs, PhD (Rockefeller University).Full story -
Tumors After Attempted Stem Cell Therapy Highlight Importance of Rigorous Standards Before Clinical Treatment
The ISSCR is concerned and saddened by the recent report of nervous system tumors that developed in a child who had previously received injections of cell preparations referred to as “neural stem cells.” This illustrates the concerns that prompted the ISSCR to develop Guidelines for the Clinical Translation of Stem Cells, released in December 2008.Full story -
ISSCR Scientists Elated for Future of Human Embryonic Stem Cell Research After Obama Lifts Funding Ban
The ISSCR applauds President Barack Obama’s decision to expand federal funding for human embryonic stem cell research by rescinding the policy of Aug. 9, 2001, which restricted federally-funded researchers to using only the small number of cell lines created before that date.Full story -
Scientists See Progress in FDA Stem Cell Trial Approval
The ISSCR shares in the excitement generated by the U.S. Food and Drug Administration‘s landmark decision to approve the first clinical trials using the products of human embryonic stem cells, yet advises the public to maintain realistic expectations at this early stage.Full story -
The ISSCR Releases New Guidelines to Shape Future of Stem Cell Therapy
The ISSCR releases Guidelines for the Clinical Translation of Stem Cells, defining a roadmap for medical researchers and doctors, outlining what needs to be accomplished to move stem cells from promising research to proven treatments for patientsFull story -
Weissman, Yamanaka and Schöler Receive Prestigious Award from German Scientific Foundation
In a ceremony today ISSCR President-Elect Irving L. Weissman (USA), Board Member Shinya Yamanaka (Japan) and Member Hans Schöler (Germany) were awarded the prestigious Robert Koch Prize by the Robert Koch Foundation. The International Society for Stem Cell Research congratulates them for earning this honor.Full story -
Scientists Urge President-Elect Obama to Restore U.S. Funding of Stem Cell Research
The ISSCR, representing the world’s leading stem cell scientists, urges President-Elect Barack Obama to restore federal funding for embryonic stem cell research in the first 100 days of his presidency.Full story -
ISSCR Applauds Outcome of Proposal 2 Advancing Stem Cell Research
On Tuesday, Michigan voters were asked to support Michigan’s Proposal 2, a state initiative to accelerate medical research and develop new stem cell treatments for currently incurable diseases. The International Society for Stem Cell Research (ISSCR), representing some of the world’s leading stem cell researchers, along with other leading scientists works to support all types of stem cell research. The vote was 53% in favor and 47% opposed to Proposal 2.Full story -
International Society for Stem Cell Research Highlights New YouTube Channel Providing Accurate Scientific Perspectives on Stem Cell Research
The University of Michigan launched a new channel on YouTube.com this week (http://www.youtube.com/UMStemCell) to highlight and share advances in stem cell science. This educational effort is supported by the University’s stem cell research programs and commended by the International Society for Stem Cell Research (ISSCR).Full story
Media Contact
